Sawgrass Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Sawgrass Asset Management's UTHR Position: Q3 2026 in Review
Sawgrass Asset Management reduced its United Therapeutics (UTHR) stake by 0.4% in Q3 2026, selling an estimated $54.8K and leaving 26,355 shares worth $14.3M. The position accounts for 1.89% of the portfolio, ranked #13.
Sawgrass Asset Management first reported a position in UTHR in Q3 2025 and has held it in 5 quarters since. The position peaked at $14.9M in Q1 2026. 841 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Sawgrass Asset Management held 26,355 shares of United Therapeutics worth $14.3M as of Q3 2026.
- Sawgrass Asset Management sold 106 United Therapeutics shares in Q3 2026, an estimated $54.8K.
- United Therapeutics made up 1.89% of Sawgrass Asset Management's portfolio in Q3 2026, its #13 holding.
- Sawgrass Asset Management first reported a position in United Therapeutics in Q3 2025 and has held it in 5 quarters since.
- Sawgrass Asset Management's United Therapeutics position peaked at $14.9M in Q1 2026.
- 841 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Sawgrass Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.